Table 1.
Participant Demographic Characteristics
| Characteristic | Without CF (n = 20) | With CF |
|
|---|---|---|---|
| Pseudomonas aeruginosa Culture Positive (n = 10) | Pseudomonas aeruginosa Culture Negative (n = 5) | ||
| Age, yr | 37 ± 12.0 | 36.2 ± 12.9 | 40 ± 13.5 |
| Female sex | 13 (65) | 3 (30) | 1 (20) |
| Race | |||
| White | 21 (100) | 9 (90) | 5 (100) |
| Black | 0 | 1 (10) | 0 |
| FEV1, % predicted | ND | 67.1 ± 8.3 | 58.4 ± 25.0 |
| FVC, % predicted | ND | 81.9 ± 12.1 | 75.6 ± 19.0 |
| FEV1/FVC | ND | 0.677 ± 0.08 | 0.61 ± 0.15 |
| Body mass index, kg/m2 | ND | 25.9 ± 5.2 | 23.7 ± 4.2 |
| CFTR modulator therapy | |||
| Elexacaftor/tezacaftor/ivacaftor | 0 | 8 (80) | 3 (60) |
| Tezacaftor/ivacaftor | 0 | 0 | 1 (5) |
| Ivacaftor | 0 | 0 | 1 (5) |
| None | 0 | 2 (20) | 0 |
Data are presented as mean ± standard deviation where applicable. Values in parentheses are percentages.
Definition of abbreviations: BMI = body mass index; CFTR = cystic fibrosis transmembrane conductance regulator; ND = not determined.